注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
北京北陆药业股份有限公司是一家主要从事对比剂产品、精神类药品和降糖类药品的研发、生产与销售的中国公司。该公司的主要产品包括钆喷酸葡胺注射液、碘海醇注射液、碘帕醇注射液、碘克沙醇注射液、枸橼酸铁胺泡腾颗粒、瑞格列奈片、格列美脲片和九味镇心颗粒等。该公司的产品主要在中国国内市场销售。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Ying Yang | 44 | 2015 | Chairman of Supervisory Board |
Ying Dian Wang | 61 | 2019 | Independent Director |
Qing Xiang | 51 | 2007 | Non-Independent Director |
Ni Zeng | 30 | 2019 | Deputy GM, Financial Director & Non-Independent Director |
Bin Zheng | - | 2022 | Independent Director |
Gang Cao | - | 2022 | Independent Director |
Xu Wang | 38 | 2015 | Chairman & GM |
Gen Chang Zheng | 55 | 2008 | Chief Engineer & Employee Representative Member of Supervisory Board |
Li Zong | 53 | 2019 | Deputy GM & Director |
Zehui Shao | 44 | 2018 | Deputy GM, Secretary of the Board of Directors & Non-Independent Director |
Chengjie Hong | 42 | 2021 | Director of R&D Center & Non-Independent Director |
Wei Jiang | 51 | 2022 | Non-Employee Supervisor |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核